The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Primary and Secondary Prevention of Cardiovascular Disease
Open accessAbstract
Background This guideline focuses on long-term administration of antithrombotic drugs designed for primary and secondary prevention of cardiovascular disease, including two new antiplatelet therapies. Methods The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines in this supplement. Results We present 23 recommendations for pertinent clinical questions. For primary prevention of cardiovascular disease, we suggest low-dose aspirin (75-100 mg/d) in patients aged > 50 years over no aspirin therapy (Grade 2B). For patients with established coronary artery disease, defined as patients 1-year post-acute coronary syndrome, with prior revascularization, coronary stenoses > 50% by coronary angiogram, and/or evidence for cardiac ischemia on diagnostic testing, we recommend long-term low-dose aspirin or clopidogrel (75 mg/d) (Grade 1A). For patients with acute coronary syndromes who undergo percutaneous coronary intervention (PCI) with stent placement, we recommend for the first year dual antiplatelet therapy with low-dose aspirin in combination with ticagrelor 90 mg bid, clopidogrel 75 mg/d, or prasugrel 10 mg/d over single antiplatelet therapy (Grade 1B). For patients undergoing elective PCI with stent placement, we recommend aspirin (75-325 mg/d) and clopidogrel for a minimum duration of 1 month (bare-metal stents) or 3 to 6 months (drug-eluting stents) (Grade 1A). We suggest continuing low-dose aspirin plus clopidogrel for 12 months for all stents (Grade 2C). Thereafter, we recommend single antiplatelet therapy over continuation of dual antiplatelet therapy (Grade 1B). Conclusions Recommendations continue to favor single antiplatelet therapy for patients with established coronary artery disease. For patients with acute coronary syndromes or undergoing elective PCI with stent placement, dual antiplatelet therapy for up to 1 year is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence supports use of either ticagrelor or clopidogrel if no percutaneous coronary intervention was performed and clopidogrel, ticagrelor, or prasugrel if a percutaneous coronary intervention was performed (199).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [199]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Evidence supports use of either ticagrelor or clopidogrel if no percutaneous coronary intervention was performed and clopidogrel, ticagrelor, or prasugrel if a percutaneous coronary intervention was performed (187).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [187]
In the citing paper
“Evidence supports use of either ticagrelor or clopidogrel if no percutaneous coronary intervention was performed and clopidogrel, ticagrelor , or prasugrel if a percutaneous coronary intervention was performed (162).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [162]
In the citing paper
“Co-prescription of OAC with antiplatelet therapy, in particular triple therapy, 1501 increases the absolute risk of major haemorrhage.445,517,518”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [517]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm
Lip, G. Y. H., Wrigley, B., & Pisters, R. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003333 · Cited by 32
RetractedPrediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Self-citationHansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Flagged first, then by citations
1 of the 118 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Wilson, 1998, Prediction of coronary artery disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 475
Bała, M. M., Paszek, E., Leśniak, W., Włoch-Kopeć, D., Jasińska, K., & Undas, A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012534.pub2 · Cited by 47
Palomo, I. F., Concha‐Meyer, A. A., Mariane Lutz, R., Said, M., Sáez, B., Vásquez, A., & Eduardo Fuentes, Q. (2019) · Nutrients · doi:10.3390/nu11020456 · Cited by 45
Aspirin and spinal haematoma after neuraxial anaesthesia: Myth or reality?
Vela-Vásquez, R. N., & Romero, R. (2015) · British Journal of Anaesthesia · doi:10.1093/bja/aev348 · Cited by 44
Iudici, M., Fasano, S., Falcone, L. G., Pantano, I., MONTAGNA, G. L., Migliaresi, S., & Valentini, G. (2016) · Rheumatology · doi:10.1093/rheumatology/kew231 · Cited by 46
Aspirin for Primary Prevention of Cardiovascular Disease Events
Nemerovski, C. W., Salinitri, F. D., Morbitzer, K. A., & Moser, L. R. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1127 · Cited by 43
Effect of β‐blockers on platelet aggregation: a systematic review and meta‐analysis
Bonten, T. N., Plaizier, C. E. I., Snoep, J. D., Stijnen, T., Dekkers, O. M., & van der Bom, J. G. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12404 · Cited by 43
Aspirin, Clopidogrel, and Ticagrelor in Acute Coronary Syndromes
Berger, J. S. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.04.055 · Cited by 39
Wong, A., Amato, M. G., Seger, D. L., Slight, S. P., Beeler, P. E., Dykes, P. C., Fiskio, J. M., Silvers, E. R., Orav, E. J., Eguale, T., et al. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.02.027 · Cited by 41
Low-dose aspirin and risk of intracranial bleeds
Soriano, L. C., Gaist, D., Soriano‐Gabarró, M., Bromley, S. E., & Rodríguez, L. A. G. (2017) · Neurology · doi:10.1212/wnl.0000000000004694 · Cited by 41
Clini, E. M., Beghé, B., & Fabbri, L. M. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201302-0230ed · Cited by 40
Aspirin in the Prevention of Cardiovascular Disease and Cancer
Ricciotti, E., & FitzGerald, G. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-051019-102940 · Cited by 41
Talle, M. A., Buba, F., & Anjorin, C. O. (2014) · Advances in Medicine · doi:10.1155/2014/731936 · Cited by 39
Chelucci, R. C., Dutra, L. A., Pires, M. L., Melo, T. D., Bosquesi, P. L., Chung, M., & dos Santos, J. L. (2014) · Molecules · doi:10.3390/molecules19022089 · Cited by 40
Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
Jung, J. H., Tantry, U. S., Gurbel, P. A., & Jeong, Y. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.2.95 · Cited by 38
Rhabdomyolysis precipitated by possible interaction of ticagrelor with high-dose atorvastatin
Kido, K., Wheeler, M. B., Seratnahaei, A., Bailey, A. L., & Bain, J. A. (2015) · Journal of the American Pharmacists Association · doi:10.1331/japha.2015.14151 · Cited by 38
Leggio, M., Bendini, M. G., Caldarone, E., Lombardi, M., Severi, P., D’Emidio, S., Stavri, D. C., Armeni, M., Bravi, V., & Mazza, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.11.002 · Cited by 37
Perioperative Aspirin Management After POISE-2
Gerstein, N. S., Carey, M. C., Cigarroa, J. E., & Schulman, P. M. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000589 · Cited by 37
Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-Dose Aspirin
Soriano, L. C., Lanas, Á., Soriano‐Gabarró, M., & Rodríguez, L. A. G. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.061 · Cited by 37
Antithrombotic Agents and Cancer
Bruno, A., Dovizio, M., Tacconelli, S., Contursi, A., Ballerini, P., & Patrignani, P. (2018) · Cancers · doi:10.3390/cancers10080253 · Cited by 37
Ram, P., Shah, M. K., Sirinvaravong, N., Lo, K. B., Patil, S., Patel, B. D., Tripathi, B., Garg, L., & Figueredo, V. M. (2018) · Clinical Cardiology · doi:10.1002/clc.23039 · Cited by 36
Venous and Arterial Thrombosis: Is There a Link?
Prandoni, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_121 · Cited by 35
Puhan, M. A., Yu, T., Stegeman, I., Varadhan, R., Singh, S., & Boyd, C. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0493-2 · Cited by 35
Aspirin for primary prevention of cardiovascular disease
Nansseu, J. R., & Noubiap, J. J. (2015) · Thrombosis Journal · doi:10.1186/s12959-015-0068-7 · Cited by 35
Development of a novel, multilayered presentation format for clinical practice guidelines.
Kristiansen, A., Brandt, L., Alonso-Coello, P., Agoritsas, T., Akl, E., Conboy, T., Elbarbary, M., Ferwana, M., Medani, W., Murad, M., et al. (2015) · Chest · doi:10.1378/chest.14-1366 · Cited by 27
Self-citationCohen, A. T., Imfeld, S., Markham, J., & Granziera, S. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.11.036 · Cited by 35
Clinical causes and treatment of the thrombotic storm
Ortel, T. L., Kitchens, C. S., Erkan, D., Brandão, L. R., Hahn, S. E., James, A., Kulkarni, R., Manco‐Johnson, M. J., Pericak‐Vance, M. A., & Vance, J. M. (2012) · Expert Review of Hematology · doi:10.1586/ehm.12.56 · Cited by 34
Bouget, J., Balusson, F., Viglino, D., Roy, P., Lacut, K., Pavageau, L., & Oger, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237022 · Cited by 32
Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention
Kohli, P., Whelton, S. P., Hsu, S., Yancy, C. W., Stone, N. J., Chrispin, J., Gilotra, N. A., Houston, B. A., Ashen, M. D., Martin, S. S., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001098 · Cited by 32
Discontinuation of preoperative clopidogrel is unnecessary in peripheral arterial surgery
Saadeh, C., & Sfeir, J. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.05.092 · Cited by 32
Anticoagulation in Ischemic Left Ventricular Aneurysm
Lee, G. Y., Song, Y. B., Hahn, J., Choi, S., Choi, J., Jeon, E., Park, S., Lee, S., Park, S. W., & Gwon, H. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.12.025 · Cited by 31
Bomb, R., Oliphant, C. S., & Khouzam, R. N. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.03.050 · Cited by 30
Targeting eukaryotic proteases for natural products-based drug development
Al‐Awadhi, F. H., & Luesch, H. (2020) · Natural Product Reports · doi:10.1039/c9np00060g · Cited by 30
Tegegn, H. G., Bhagavathula, A. S., Abebe, T. B., & Belachew, S. A. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s107394 · Cited by 31
Reintroduction of anti‐thrombotic therapy after a gastrointestinal haemorrhage: if and when?
Scott, M. J., Veitch, A., & Thachil, J. V. (2017) · British Journal of Haematology · doi:10.1111/bjh.14599 · Cited by 30
Haas, S. K., Bode, C., Norrving, B. G., & Turpie, A. G. G. (2014) · Vascular Health and Risk Management · doi:10.2147/vhrm.s55246 · Cited by 29
Shokr, M., Ahmed, A., Abubakar, H., SayedAhmad, Z., Rashed, A., Afonso, L., & Cardozo, S. J. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1917 · Cited by 29
The aspirin controversy in primary prevention
Raju, N. C., & Eikelboom, J. W. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328356ae95 · Cited by 28
Patrick, J., Dillaha, L., Armas, D. R., & Sessa, W. C. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2015.1050341 · Cited by 28
Kovács, E., Katona, Ë., Bereczky, Z., Homoródi, N., Balogh, L., Tóth, E., Péterfy, H., Kiss, R. G., Edes, I. F., & Muszbek, L. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.01.033 · Cited by 27
Hwang, I., Jeon, J.-Y., Kim, Y., Kim, H. M., Yoon, Y. E., Lee, S.-P., Kim, H.-K., Sohn, D.-W., Sung, J., & Kim, Y.-J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129584 · Cited by 26
Aspirin for Cardioprotection and Strategies to Improve Patient Adherence
Duffy, D., Kelly, E. M., Trang, A., Whellan, D. J., & Mills, G. D. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.01.2721 · Cited by 27
Wang, J., Zeng, Z., Dong, R., Sheng, J., Lai, Y., Yu, J., & Zuo, H. (2020) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x20960639 · Cited by 26
Cardiovascular Health Disparities in Underserved Populations
Mouton, C. P., Hayden, M., & Southerland, J. H. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.09.019 · Cited by 26
Schaefer, J., Errickson, J., Gu, X., Alexandris-Souphis, T., Ali, M. A., Haymart, B., Kaatz, S., Kline-Rogers, E., Kozlowski, J., Krol, G., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.31973 · Cited by 17
Herath, H. M. M. T. B., Pahalagamage, S. P., Lindsay, L. C., Vinothan, S., Withanawasam, S., Senarathne, V., & Withana, M. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0616-0 · Cited by 25
Chen, P., Tang, L., Yi, J., Pei, J., & Hu, X. (2019) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.10.029 · Cited by 25
Santilli, F., Pignatelli, P., Violi, F., & Davì, G. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-03-0202 · Cited by 25
Patel, V., Lin, F., Ojo, O., Rao, S., Yu, S., Zhan, L., & Touchette, D. R. (2014) · Pharmacy Practice · doi:10.4321/s1886-36552014000300007 · Cited by 24
Coleman, C. I., & Limone, B. L. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.03.036 · Cited by 24
Dopheide, J. F., Rubrech, J., Trumpp, A., Geißler, P., Zeller, G. C., Bock, K., Dünschede, F., Trinh, T. T., Dorweiler, B., Münzel, T. F., et al. (2016) · Platelets · doi:10.3109/09537104.2016.1153619 · Cited by 24
Mammography Screening for Breast Cancer
Smith, R. A., Kerlikowske, K. M., Miglioretti, D. L., & Kalager, M. (2012) · New England Journal of Medicine · doi:10.1056/nejmclde1212888 · Cited by 23
Cairns, J. A. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.05.010 · Cited by 22
Fosbøl, E. L., Ju, C., Anstrom, K. J., Zettler, M. E., Messenger, J. C., Waksman, R., Effron, M. B., Baker, B., Cohen, D. J., Peterson, E. D., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.115.003602 · Cited by 22
Potential Role of Endogenous Adenosine in Ticagrelor‐Induced Dyspnea
Belchikov, Y. G., Koenig, S. J., & DiPasquale, E. M. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1293 · Cited by 22
Rational use of medicines: prescribing indicators at different levels of health care
Ferreira, M. B. C., Heineck, I., Flores, L. M., Camargo, A. L., Pizzol, T. D. S. D., Torres, I. L. D. S., Köenig, Á., Trevisol, D. J., de Melo, A. M. M. F., Cardoso, T. F. M., et al. (2013) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502013000200015 · Cited by 22
Hahn, K. Y., Park, J. C., Lee, Y. K., Shin, S. K., Lee, S. K., & Lee, Y. C. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13990 · Cited by 21
Wein, T. H., Lindsay, M. P., Gladstone, D. J., Poppe, A. Y., Bell, A., Casaubon, L. K., Foley, N. C., Coutts, S. B., Cox, J. L., Douketis, J. D., et al. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.191599 · Cited by 19
Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review
Sedhom, R., Abdelmaseeh, P., Megaly, M. S., & ASINGER, R. W. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.012 · Cited by 20
Battistoni, A., Mastromarino, V., & Volpe, M. (2015) · Clinical Cardiology · doi:10.1002/clc.22394 · Cited by 20
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin
Packard, K. A., & Hilleman, D. E. (2016) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12211 · Cited by 21
In Vitro Selection of Specific DNA Aptamers Against the Anti-Coagulant Dabigatran Etexilate
Aljohani, M. M., Chinnappan, R., Eissa, S., Alsager, O. A., Weber, K., Cialla‐May, D., Popp, J., & Zourob, M. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-31327-3 · Cited by 20
Shah, R., Khan, B., Latham, S. B., Khan, S., & Rao, S. V. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.05.015 · Cited by 20
Use of dabigatran for treatment of left ventricular thrombus: A tertiary care center experience
Verma, B., Singh, A., & Kumar, M. (2019) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_459_19 · Cited by 20
Impact of Sex and Gender on the Efficacy of Antiplatelet Therapy: The Female Perspective
Basili, S., Raparelli, V., Proietti, M., Tanzilli, G., & Franconi, F. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24935 · Cited by 20
Sigvant, B., Henriksson, M., Lundin, F., & Wahlberg, E. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826710389368 · Cited by 20
Confirmation of Reported Aspirin Use in Community Studies
Zantek, N. D., Luepker, R. V., Duval, S., Miller, K. H., Oldenburg, N. C., & Hirsch, A. T. (2013) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029613486537 · Cited by 20
Bleeding risks associated with vitamin K antagonists
Linkins, L. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.02.004 · Cited by 24
Kovács, E., Katona, É., Bereczky, Z., Homoródi, N., Balogh, L., Tóth, E., Péterfy, H., Kiss, R. G., Edes, I. F., & Muszbek, L. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.10.008 · Cited by 19
Norgard, N. B., & DiNicolantonio, J. J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2682 · Cited by 22
La formulación de recomendaciones en salud: el sistema GRADE
Alonso‐Coello, P., Comas, D. R., Solà, I., & García, L. M. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.10.012 · Cited by 19
Self-citationAnticoagulation Therapy and NOACs in Heart Failure
Thomas, I. C., EncisoSilva, J., Schlueter, M., & Greenberg, B. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_126 · Cited by 19
Anticoagulation in the cardiac patient: A concise review
Larson, E. A., German, D. M., Shatzel, J. J., & DeLoughery, T. G. (2018) · European Journal Of Haematology · doi:10.1111/ejh.13171 · Cited by 22
Trajectories of Adherence to Low-Dose Aspirin Treatment Among the French Population
AJROUCHE, A., Estellat, C., Rycke, Y. D., & Tubach, F. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419865287 · Cited by 19
Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements
Antón, A. I., Cerezo-Manchado, J. J., Padilla, J., Pérez-Andreu, V., Corral, J., Vicente, V., Roldán, V., & Gónzález‐Conejero, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064469 · Cited by 18
Optimizing the Use of Aspirin for Cardiovascular Prevention
Casado-Arroyo, R., Sostres, C., & Lanas, Á. (2013) · Drugs · doi:10.1007/s40265-013-0061-z · Cited by 18
Rodríguez, L. A. G., Lanas, Á., Soriano‐Gabarró, M., & Soriano, L. C. (2019) · Annals of Medicine · doi:10.1080/07853890.2019.1591635 · Cited by 22
Kılıç, S., Çelik, A., Çekirdekçi, E. İ., Altay, S., Elçik, D., Akboğa, M. K., Durukan, M. K., Yayla, Ç., & Zoghi, M. (2018) · Balkan Medical Journal · doi:10.4274/balkanmedj.2017.1472 · Cited by 18
The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists
Houle, S. K. D., Padwal, R. S., Poirier, L., & Tsuyuki, R. T. (2015) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163515586847 · Cited by 16
Determination of Aspirin Using Functionalized Cadmium-Tellurium Quantum Dots as a Fluorescence Probe
Li, H., Wei, X., Xu, Y., Hao, T., Dai, J., Wang, J., Gao, L., & Yan, Y. (2015) · Analytical Letters · doi:10.1080/00032719.2014.974055 · Cited by 17
Brieger, D. B., & Redfern, J. (2013) · The Medical Journal of Australia · doi:10.5694/mja12.11224 · Cited by 17
Li, T., Liu, M., He, B., Xu, Z., Zhong, H., & Wu, B. Y. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0290-x · Cited by 17
Sulaica, E. M., Macaulay, T. E., Helbing, R. R., Abo-Aly, M. A., Abdel‐Latif, A., & Wanat, M. A. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09818-w · Cited by 16
Use of Heparin in Acute Ischemic Stroke: Is There Still a Role?
Ruff, I., & Jindal, J. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0528-3 · Cited by 16
Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease
Minno, G. D., Spadarella, G., Cafaro, G., Petitto, M., Lupoli, R., Minno, A. D., de Gaetano, G., & Tremoli, E. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.932618 · Cited by 21
Rothweiler, R. M., Gerlach, V., Voss, P. J., Poxleitner, P. J., Ermer, M. A., Groß, C., Schwer, C. I., Vach, K., Kalbhenn, J., & Metzger, M. C. (2022) · Journal of Stomatology Oral and Maxillofacial Surgery · doi:10.1016/j.jormas.2022.03.001 · Cited by 16
Ticagrelor as an alternative in clopidogrel-associated neutropenia
Shah, R., Keough, L. A., Belalcazar, A., & Ramanathan, K. B. (2014) · Platelets · doi:10.3109/09537104.2013.867427 · Cited by 16
Rodríguez, L. A. G., Soriano‐Gabarró, M., Vora, P., & Soriano, L. C. (2020) · International Journal of Cancer · doi:10.1002/ijc.33022 · Cited by 16
Bała, M. M., Paszek, E., Włoch-Kopeć, D., Leśniak, W., & Undas, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012534 · Cited by 16
Patel, S. G., Lowery, J. T., Gatof, D., & Ahnen, D. J. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3567-2 · Cited by 15
Huo, Y., Thompson, P. L., Buddhari, W., Ge, J., Harding, S. A., Letchuman, R., Reyes, E. B., Santoso, A., Tam, L.-W., Vijayaraghavan, G., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.195 · Cited by 15
The lack of aspirin resistance in patients with coronary artery disease
Homoródi, N., Kovács, E., Leé, S., Katona, É., Shemirani, A. H., Haramura, G., Balogh, L., Bereczky, Z., Szőke, G., Péterfy, H., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0827-7 · Cited by 15
Monitoring Antiplatelet Aggregation In Vivo and In Vitro by Microtiter Plate Method
Wu, Q., Dong, J., Zeng, H., Lv, C., Liu, A., & Zhang, W. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000801 · Cited by 15
Eikelboom, J. W., Hirsh, J., Spencer, F. A., Baglin, T. P., & Weitz, J. I. (2014) · Cited by 14
Self-citationHusted, S., & Boersma, E. H. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000237 · Cited by 14
Bose, S., Stonko, D. P., Pappas, G. M., Drudi, L. M., Stoner, M. C., & Hicks, C. W. (2022) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2022.09.028 · Cited by 14
Acute Myocardial Infarction During Pregnancy
Pacheco, L. D., Saade, G. R., & Hankins, G. D. V. (2014) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000065 · Cited by 14
Springer, S. P., Mor, M. K., Sileanu, F. E., Zhao, X., Aspinall, S. L., Ersek, M. T., Niznik, J. D., Hanlon, J. T., Hunnicutt, J. N., Gellad, W. F., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16346 · Cited by 15
Narala, K. R., Hassan, S., Lalonde, T. A., & McCullough, P. A. (2013) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2012.12.004 · Cited by 13
Bem, D., Lordkipanidzé, M., Hodgkinson, J., Stevens, S., Bayliss, S. E., Moore, D., Fitzmaurice, D., & Dretzke, J. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.438 · Cited by 13
Wada, S., Iwanaga, Y., Nakai, M., Miyamoto, Y., & Noguchi, T. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02187-9 · Cited by 13
Metadata
- Authors
- Vandvik, P. O., Lincoff, A. M., Gore, J. M., Gutterman, D. D., Sonnenberg, F. A., Alonso-Coello, P., Akl, E. A., Lansberg, M. G., Guyatt, G. H., & Spencer, F. A.
- Affiliations
- Innlandet Hospital Trust (NO)
- Cleveland Clinic (US)
- University of Massachusetts Chan Medical School (US)
- Medical College of Wisconsin (US)
- University of Medicine and Dentistry of New Jersey (US)
- University at Buffalo, State University of New York (US)
- Stanford Medicine (US)
- McMaster University (CA)
- Corresponding author
- Spencer, Frederick A.
- ORCID
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 141
- Issue
- 2
- Pages
- e637S-e668S
- ISSN
- 0012-3692 (ISSN-L)
- PMC
- PMC3278064
- OpenAlex
- W2116051185
- Cited by
- 476
- References
- 118
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 11 · 2023: 6 · 2022: 23 · 2021: 19 · 2020: 32 · 2019: 36 · 2018: 29 · 2017: 44 · 2016: 46 · 2015: 59 · 2014: 58 · 2013: 64 · 2012: 37
- FWCI
- 44.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- CHEST Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- Sanofi
- National Heart, Lung, and Blood Institute (R13HL104758)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- cardiovascular disease prevention, antithrombotic therapy, antiplatelet therapy, low-dose aspirin, clopidogrel, ticagrelor, prasugrel, dual antiplatelet therapy, single antiplatelet therapy, acute coronary syndrome, percutaneous coronary intervention, coronary artery disease, drug-eluting stents, bare-metal stents, long-term aspirin therapy
- MeSH terms
- Aged, Cardiovascular Diseases, Combined Modality Therapy, Coronary Disease, Dose-Response Relationship, Drug, Drug Therapy, Combination, Fibrinolytic Agents, Humans, Long-Term Care, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Societies, Medical, Thrombosis, Stents, Angioplasty, Balloon, Coronary, Myocardial Ischemia, Evidence-Based Medicine, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
